Oz Gul, Ozen <br/><br/>
Comparative genotoxic and cytotoxic effects of the oral antidiabetic drugs sitagliptin, rosiglitazone, and pioglitazone in patients with type-2 diabetes: a cross-sectional, observational pilot study.  [electronic resource] 

 -  Mutation research  Sep 2013 
 - 31-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0027-5107 
<br/><br/><label>Standard No.: </label>10.1016/j.mrgentox.2013.04.024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Blood Glucose<br/>Chromosome Aberrations--drug effects<br/>Cross-Sectional Studies<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Female<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Male<br/>Micronuclei, Chromosome-Defective--drug effects<br/>Middle Aged<br/>Pilot Projects<br/>Pioglitazone<br/>Pyrazines--administration & dosage<br/>Rosiglitazone<br/>Sister Chromatid Exchange--drug effects<br/>Sitagliptin Phosphate<br/>Thiazolidinediones--administration & dosage<br/>Triazoles--administration & dosage